A Closer Look at Affinity Ligands

Feature
Article
Pharmaceutical TechnologyBio/Pharma Outsourcing Innovation, February 2024 eBook
Volume 2024 eBook
Issue 2
Pages: 16-21

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo

Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo

Affinity ligands play an exciting role in the ever-growing sphere of downstream processing. In speaking with Pharmaceutical Technology®, Phillip Elliott, PhD, associate director of Process Development, BioCina; Jan Bekker, PhD, director, Business Development, Commercial and Technical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a deeper understanding of the role affinity ligands play in the future of downstream processing.

Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.

About the author

Daria Husni is assistant editor to Pharmaceutical Technology® and Pharmaceutical Technology Europe®.

Article details

Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 16-21

Citation

When referring to this article, please cite it as Husni, D. A Closer Look at Affinity Ligands. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.

Articles in this issue
Blockchain supply chain business smart contract solution network protocol - illustration rendering | Image Credit - © immimagery - © immimagery - stock.adobe.com
Pharmaceutical Outsourcing Present and Future
Blister packed medication in sterile hypodermic syringes | Image Credit - © kenwnj - © kenwnj - stock.adobe.com
Managing the Complexity of Modern Sterile Product Developments
Scientist holding liquid biological sample. Medical technology research institute concept, molecule inside liquid bubble, 3d illustration. | Image Credit - © fgnopporn - © fgnopporn - stock.adobe.com
Navigating the Preclinical CRO Outsourcing Process
Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo
A Closer Look at Affinity Ligands
Science team, tablet and analysis study in lab for pharmaceutical collaboration, scientist teamwork and working on research. Medical analysis, laboratory innovation and pharamacy partnership on device. | Image credit: ©J Bettencourt/peopleimages.com - stock.adobe.com
Ensuring Quality in Contracted Support
medicine science factory staff worker check quality products sterilize in autoclave tank in check list. | Image Credit: ©Quality Stock Arts - stock.adobe.com
How to Evaluate a CDMO’s Commitment to Quality
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Patrick Lavery
May 15th 2025
Article

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Feb 2, 2020 South San Francisco / CA / USA - Genentech headquarters in Silicon Valley; Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009 | Image Credit: © Sundry Photography - stock.adobe.com

Genentech and Roche Expand US Footprint with New North Carolina Manufacturing Facility

Patrick Lavery
May 13th 2025
Article

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

A laboratory technician performing a quality control test on a batch of pharmaceutical tablets, highlighting the importance of ensuring drug safety. | Image Credit: ©MAY -stock.adobe.com

Poor API Quality Threatens a Healthy Supply

Susan Haigney
May 9th 2025
Article

Poor API quality may often lead to delays in production and a shortage of supply.

Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.